Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol

International Journal of Pharmaceutics

Volumn 228, Issue 1-2, 2001, Pages 43-52

  Agarwal, R ^a   Katare, O P ^a   Vyas, S P ^b  

^a PANJAB UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Dithranol; Entrapment efficiency; Liposomes; Niosomes; Skin permeation; Stability; Topical delivery

Indexed keywords

ANTIPSORIASIS AGENT; CHOLESTEROL; DITHRANOL; LIPOSOME; NIOSOME; PHOSPHATIDYLCHOLINE; SORBITAN STEARATE;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; HIGH TEMPERATURE; HYDRATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SKIN; TEMPERATURE DEPENDENCE;

ADMINISTRATION, TOPICAL; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; DIFFUSION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; PARTICLE SIZE; PERMEABILITY; REPRODUCIBILITY OF RESULTS; SOLUBILITY;

EID: 0035834185     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00810-9     Document Type: Article

References (20)

1. Therapeutic strategies for psoriasis
2. Diffusion of univalent ions across the lamellae of swollen phospholipids
3. Study of the interaction of dithranol with heptakis(2,3,6 tri-O-methyl)- β cyclodextrin in solution and in the solid state
4. Transferosomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration and transdermal drug delivery
5. Preparation and study of the characteristics of dithranol: Polyvinylpyrrolidone coevaporates
6. Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes
7. How stable is dithranol? An investigation into the degradation of different dithranol formulations
8. Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): A new approach in the treatment of psoriasis
9. Anthralin: How does it act and are there more favorable derivatives
10. Irritation, staining and antipsoriatic activity of 10-acyl analogue of anthralin
11. Encapsulation and stability of clofazimine liposomes
12. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage
13. Cosmetic application of liposomes
14. Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes
15. Non-ionic surfactant based vesicles (niosomes) in drug delivery
16. A novel dithranol formulation (micanol): The effects of monotherapy and ultraviolet B combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris
17. Influence of liposome bilayer fluidity on the transport of encapsulated substance into the skin as evaluated by EPR
18. The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin
19. Pharmaceutical formulations of anthralin